NICK POMONIS: Open Payments
NPI 1225034168 · ORANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 49 payments from 16 companies in 2025. Trend: 2023 $845 · 2024 $1,330 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $398 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $283 |
| ABBVIE INC. | 9 | $150 |
| Antares Pharma, Inc. | 1 | $149 |
| Inspire Medical Systems, Inc. | 3 | $112 |
| Axsome Therapeutics, Inc. | 3 | $103 |
| Teva Pharmaceuticals USA, Inc. | 2 | $95 |
| Amgen Inc. | 4 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $45 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, XYOSTED, FARXIGA, INSPIRE, Auvelity, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
